Trials / Terminated
TerminatedNCT04594681
A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration
A Phase I Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 116 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate safety and tolerability after administration of KHK4951 in healthy volunteers and patients with wet age-related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo is administered once daily or three times daily. |
| DRUG | KHK4951 | KHK4951 is administered once daily or three times daily. |
Timeline
- Start date
- 2020-09-16
- Primary completion
- 2022-08-26
- Completion
- 2022-08-26
- First posted
- 2020-10-20
- Last updated
- 2023-05-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04594681. Inclusion in this directory is not an endorsement.